Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tecan Group AG (TECN.SW)
CHF183.60
-1.40 (-0.76%)
CH SIX Healthcare Medical - Diagnostics & Research
Address
Seestrasse 103 8708
Männedorf, CH
Männedorf, CH
CEO
Monica Manotas
Website
tecan.com
IPO
1995-04-10
ISIN CH0012100191
Also trades on
London Stock Exchange · 0QLN.L (CHF)
Other OTC · TCGGY (USD)
Other OTC · TCHBF (USD)
Swiss Exchange · TECN.SW (CHF)
Description
Tecan Group AG, established in 1980 and headquartered in Männedorf, Switzerland, specializes in providing cutting-edge laboratory instruments and holistic solutions. The company caters to a broad spectrum of clients, including pharmaceutical and biotechnology corporations, university research departments, and forensic and diagnostic laboratories. Its operations are structured into two principal segments: Life Sciences Business and Partnering Business. Tecan's extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, reagents for Next-Generation Sequencing (NGS), immunoassays, microbodies, and specialized software. Key proprietary solutions include Tecan Laberwax for automated workflows and Resolvex, an intelligent sample preparation system applicable across diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA. Additionally, Tecan develops and manufactures crucial components—like precision pumps, valves, robotic arms, and developer software—for other laboratory instrument producers serving life science research, diagnostics, and various industrial applications. Its advanced platform-based automation solutions include Synergence, Freedom EVO, and Fluent instruments. The company's global footprint spans Switzerland, other European nations, North America, Asia, and other international markets.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CHF183.60
-1.40 (-0.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
55.6K
Beta
1.07
Float Shares
12.50M
Free Float %
98.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.44% | +4.02% | +32.03% | +14.10% | +12.28% | +17.19% | -2.26% | -55.45% | -65.23% | +5.71% | +2,468.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
183.60
DCF (Unlevered)
127.33
-30.6%
DCF (Levered)
123.82
-32.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
38% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.58
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%-5.5% Q4'25: -16.9% (vs Q4'23)
-
EPS growth Medical - Diagnostics & Research: +30.8%-265.8% Q4'25: -265.3% (vs Q4'23)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+6.2% Q4'25: +10.8% (vs Q4'23)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+4.8% Q4'25: +4.9% (vs Q4'23)
-
ROIC Medical - Diagnostics & Research: +5.2%+4.0% Q4'25: +8.2% (vs Q4'23)
-
Share dilution Medical - Diagnostics & Research: 0.0%-0.9% ★ Q4'25: -1.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×5.18× ★ Q4'25: 2.52× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 7 EPS Ana. |
Dec 2027 8 Rev. Ana. 7 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
357.28M
est.
|
332.18M
est: 351.37M (-5.5%)
|
311.61M
est: 312.66M (-0.3%)
|
285.98M
est: 295.38M (-3.2%)
|
344.90M
est: 348.43M (-1.0%)
|
405.93M
est: 416.04M (-2.4%)
|
414.40M
est: 419.12M (-1.1%)
|
396.04M
est: 403.30M (-1.8%)
|
391.91M
est: 391.55M (+0.1%)
|
370.55M
est: 375.10M (-1.2%)
|
376.97M
est: 374.73M (+0.6%)
|
391.11M
est: 399.58M (-2.1%)
|
388.29M
est: 403.24M (-3.7%)
|
399.52M
est: 388.77M (+2.8%)
|
440.30M
est: 449.11M (-2.0%)
|
506.23M
est: 512.58M (-1.2%)
|
548.56M
est: 556.30M (-1.4%)
|
593.80M
est: 587.32M (+1.1%)
|
636.82M
est: 646.66M (-1.5%)
|
730.88M
est: 708.04M (+3.2%)
|
946.62M
est: 957.79M (-1.2%)
|
1.14B
est: 1.12B (+1.7%)
|
1.07B
est: 1.00B (+7.4%)
|
934.28M
est: 930.62M (+0.4%)
|
882.48M
est: 881.04M (+0.2%)
|
882.35M
868.88M – 905.87M
+0.1% YoY
|
926.01M
908.13M – 952.09M
+4.9% YoY
|
979.06M
977.16M – 980.96M
+5.7% YoY
|
1.04B
1.02B – 1.07B
+6.3% YoY
|
1.09B
1.07B – 1.12B
+4.9% YoY
|
| EBITDA |
78.77M
est.
|
59.03M
est: 80.16M (-26.4%)
|
42.83M
est: 50.99M (-16.0%)
|
29.40M
est: 31.43M (-6.5%)
|
33.25M
est: 32.91M (+1.0%)
|
64.22M
est: 33.19M (+93.5%)
|
75.36M
est: 63.47M (+18.7%)
|
74.09M
est: 72.84M (+1.7%)
|
70.22M
est: 71.16M (-1.3%)
|
59.06M
est: 67.35M (-12.3%)
|
62.76M
est: 38.26M (+64.0%)
|
63.08M
est: 72.08M (-12.5%)
|
61.01M
est: 63.68M (-4.2%)
|
64.41M
est: 64.31M (+0.2%)
|
74.14M
est: 60.56M (+22.4%)
|
86.67M
est: 93.10M (-6.9%)
|
92.29M
est: 91.63M (+0.7%)
|
105.64M
est: 109.79M (-3.8%)
|
117.70M
est: 109.02M (+8.0%)
|
154.99M
est: 118.78M (+30.5%)
|
201.22M
est: 129.71M (+55.1%)
|
210.85M
est: 139.02M (+51.7%)
|
205.57M
est: 158.84M (+29.4%)
|
147.80M
est: 147.42M (+0.3%)
|
42.17M
est: 139.94M (-69.9%)
|
140.14M
138.00M – 143.88M
+0.1% YoY
|
147.08M
144.24M – 151.22M
+4.9% YoY
|
155.51M
155.20M – 155.81M
+5.7% YoY
|
165.27M
162.41M – 169.81M
+6.3% YoY
|
173.40M
170.40M – 178.16M
+4.9% YoY
|
| EBIT |
76.79M
est.
|
43.62M
est: 64.55M (-32.4%)
|
20.99M
est: 39.78M (-47.2%)
|
17.93M
est: 21.27M (-15.7%)
|
22.09M
est: 21.71M (+1.8%)
|
52.51M
est: 29.61M (+77.3%)
|
64.27M
est: 51.28M (+25.3%)
|
33.99M
est: 58.02M (-41.4%)
|
62.47M
est: 30.29M (+106.2%)
|
59.06M
est: 57.10M (+3.4%)
|
53.66M
est: 55.94M (-4.1%)
|
52.97M
est: 54.70M (-3.2%)
|
54.46M
est: 52.78M (+3.2%)
|
57.64M
est: 52.83M (+9.1%)
|
66.93M
est: 66.93M (0.0%)
|
66.01M
est: 76.18M (-13.3%)
|
81.76M
est: 74.29M (+10.1%)
|
84.06M
est: 84.86M (-0.9%)
|
83.86M
est: 96.21M (-12.8%)
|
119.54M
est: 94.70M (+26.2%)
|
142.11M
est: 103.41M (+37.4%)
|
143.96M
est: 110.83M (+29.9%)
|
135.14M
est: 107.16M (+26.1%)
|
81.45M
est: 99.46M (-18.1%)
|
42.17M
est: 94.41M (-55.3%)
|
94.55M
93.11M – 97.07M
+0.1% YoY
|
99.23M
97.31M – 102.02M
+4.9% YoY
|
104.91M
104.71M – 105.12M
+5.7% YoY
|
111.50M
109.57M – 114.56M
+6.3% YoY
|
116.99M
114.96M – 120.20M
+4.9% YoY
|
| Net Income |
52.38M
est.
|
32.97M
est: 46.65M (-29.3%)
|
14.08M
est: 29.36M (-52.0%)
|
12.72M
est: 13.51M (-5.8%)
|
13.95M
est: 14.98M (-6.9%)
|
40.64M
est: 16.72M (+143.1%)
|
52.38M
est: 40.90M (+28.1%)
|
25.62M
est: 50.42M (-49.2%)
|
49.34M
est: 24.85M (+98.5%)
|
16.20M
est: 47.23M (-65.7%)
|
47.56M
est: 16.18M (+193.9%)
|
42.16M
est: 50.76M (-16.9%)
|
45.67M
est: 42.59M (+7.2%)
|
40.22M
est: 44.06M (-8.7%)
|
57.15M
est: 47.06M (+21.4%)
|
54.54M
est: 65.02M (-16.1%)
|
66.55M
est: 59.47M (+11.9%)
|
70.70M
est: 70.12M (+0.8%)
|
73.17M
est: 76.81M (-4.7%)
|
103.69M
est: 78.12M (+32.7%)
|
121.66M
est: 85.30M (+42.6%)
|
121.13M
est: 91.42M (+32.5%)
|
132.08M
est: 101.34M (+30.3%)
|
67.66M
est: 80.57M (-16.0%)
|
-110.65M
est: 72.17M (-253.3%)
|
77.41M
68.26M – 86.56M
+7.3% YoY
|
92.24M
81.11M – 103.37M
+19.2% YoY
|
114.68M
90.66M – 138.70M
+24.3% YoY
|
134.18M
131.16M – 138.97M
+17.0% YoY
|
142.04M
138.84M – 147.11M
+5.9% YoY
|
| SGA |
119.49M
est.
|
91.84M
est: 100.13M (-8.3%)
|
85.38M
est: 80.71M (+5.8%)
|
36.16M
est: 81.83M (-55.8%)
|
35.23M
est: 101.21M (-65.2%)
|
39.99M
est: 114.27M (-65.0%)
|
40.53M
est: 105.68M (-61.7%)
|
118.81M
est: 107.96M (+10.0%)
|
100.38M
est: 115.34M (-13.0%)
|
93.89M
est: 96.18M (-2.4%)
|
94.46M
est: 93.81M (+0.7%)
|
95.48M
est: 100.77M (-5.2%)
|
91.67M
est: 95.26M (-3.8%)
|
102.52M
est: 86.87M (+18.0%)
|
110.08M
est: 118.67M (-7.2%)
|
124.85M
est: 122.81M (+1.7%)
|
135.74M
est: 133.91M (+1.4%)
|
140.75M
est: 140.69M (+0.0%)
|
149.54M
est: 149.78M (-0.2%)
|
171.93M
est: 155.81M (+10.3%)
|
195.57M
est: 170.14M (+14.9%)
|
214.23M
est: 182.36M (+17.5%)
|
191.63M
est: 199.04M (-3.7%)
|
183.33M
est: 184.73M (-0.8%)
|
200.09M
est: 175.35M (+14.1%)
|
175.61M
172.93M – 180.29M
+0.1% YoY
|
184.30M
180.74M – 189.49M
+4.9% YoY
|
194.86M
194.48M – 195.24M
+5.7% YoY
|
207.10M
203.51M – 212.78M
+6.3% YoY
|
217.29M
213.52M – 223.25M
+4.9% YoY
|
| EPS |
3.59
est.
|
2.58
est: 2.84 (-9.2%)
|
1.21
est: 1.85 (-34.6%)
|
1.16
est: 1.40 (-16.9%)
|
1.26
est: 1.37 (-8.3%)
|
3.54
est: 3.25 (+9.1%)
|
4.54
est: 4.44 (+2.4%)
|
2.35
est: 4.30 (-45.4%)
|
4.77
est: 4.28 (+11.5%)
|
1.55
est: 3.74 (-58.6%)
|
4.42
est: 4.15 (+6.5%)
|
3.92
est: 4.10 (-4.5%)
|
4.16
est: 4.12 (+1.0%)
|
3.63
est: 4.30 (-15.5%)
|
5.05
est: 5.35 (-5.7%)
|
4.74
est: 4.92 (-3.6%)
|
5.67
est: 5.90 (-3.9%)
|
6.02
est: 6.33 (-4.8%)
|
6.18
est: 6.58 (-6.1%)
|
8.69
est: 7.58 (+14.7%)
|
9.95
est: 11.56 (-13.9%)
|
9.53
est: 11.49 (-17.0%)
|
10.34
est: 7.93 (+30.3%)
|
5.29
est: 6.32 (-16.3%)
|
-8.74
est: 5.77 (-251.4%)
|
6.01
5.39 – 6.84
+4.0% YoY
|
7.27
6.41 – 8.16
+21.0% YoY
|
8.74
7.16 – 10.95
+20.2% YoY
|
10.60
10.36 – 10.98
+21.3% YoY
|
11.22
10.97 – 11.62
+5.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
217.57M
OE per share TTM
17.02
Owner's Yield
11.05%
Maintenance CapEx ratio
106.79%
Maint CapEx / Avg PPE
13.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 92 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ROBO Global Robotics and Automation Index ETF ROBO | 1.44% | 26.48M | 0.95% |
| 2 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTZ.L | 0.90% | 1.40M | 0.50% |
| 3 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTG.L | 0.90% | 228.9K | 0.50% |
| 4 | First Trust Nasdaq Artificial Intelligence and Robotics ETF ROBT | 0.88% | 6.44M | 0.65% |
| 5 | Global X - Robotics & Artificial Intelligence ETF BOTZ | 0.63% | 21.80M | 0.68% |
| 6 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.40% | 1.28M | 0.31% |
| 7 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.32% | 3.71M | 0.40% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.19% | 653.7K | 0.23% |
| 9 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.19% | 653.7K | 0.23% |
| 10 | iShares MSCI Europe Small-Cap ETF IEUS | 0.18% | 316.2K | 0.41% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
13.7K
Shares Outstanding
12.66M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Monica Manotas | Chief Executive Officer, Interim Head of the Partnering Business division & Member of Management Board | 1M | female |
| Tania Micki | Chief Financial Officer & Member of Management Board | 636.0K | female |
| Erik Norström | Head of Corporate Development, Executive Vice President & Member of Management Board | — | male |
| Ingrid Purgstaller | Chief People Officer & Member of the Management Board | — | female |
| Marco Felicioni | Head of Environment, Health & Safety Office | — | — |
| Martin Brandle | Senior Vice President of Corporate Communications & Investor Relations | — | male |
| Mukta Acharya | EVP, Head of the Life Sciences Business Division & Member of the Management Board | — | female |
| Sarah Vowles | Director Sustainability & Corporate Communications | — | — |
| Ulrich Kanter | Executive Vice President, Global Head of Operations & IT and Member of Management Board | — | — |
| Andreas Wilhelm | EVP of Legal, Qua. & Regu. Affairs, Gen. Cou., Sec. of the Board of Dir. & Mem. of Mgmt Board | — | male |
| Wolfgang Deuringer | President of Sales International | — | male |
| Carsten Boegh | Chief Technology Officer, Executive Vice President, Head Research & Development & Member of the Management Board | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TECN.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
